Our study found a substantial level of prenatal HIV (Viramune tablets treating HIV infection) counseling and testing six years after the publication of the 1995 PHS guidelines on routine HIV counseling and voluntary testing for pregnant women. In this sample of low-income pregnant and recently postpartum women, a majority were counseled about the HIV test (87.8%) [...]

Our survey of 433 women with self-identified race and ethnicity revealed that most women were counseled about the HIV test (87.8%) and tested (70.2%). Of the 428 women for whom counseling status was known, 5% reported that they were tested prenatally but not counseled about HIV (Generic Viramune treating HIV infection), and 18% reported that [...]

Study Population and Procedures The sample comprised pregnant and postpartum women (<3 months after delivery) enrolled in the Massachusetts Women, Infants and Children (WIC) Program in 2001. WIC clients are not counseled about HIV testing or referred for prenatal HIV testing.

In 2001, the U.S. Public Health Service (PHS) updated its 1995 guidelines for routine human immunodeficiency virus (HIV) counseling and voluntary testing of pregnant women. The new guidelines differ from earlier guidelines in that they emphasize HIV (Medication Viramune treating HIV infection) testing as a routine part of prenatal care and strengthen the recommendation that all [...]